XtalPi Stock Jumps on Chairman's HK$32 Million Share Purchase Plan

Shares of XtalPi Holdings (2228.HK) surged on Monday after the company disclosed that its Chairman and Co-founder, Wen Shuhao, plans to purchase a significant block of the company's stock on the open market. The news was interpreted by investors as a strong vote of confidence from a key insider, sending the stock up 5.8% to HK$8.49.

Insider Buying Signals Confidence

According to a company announcement, Wen intends to acquire up to HK$32 million (approximately USD $4.1 million) in XtalPi shares using his personal funds. The purchases are slated to be completed before the end of October 2026.

The company stated that the move reflects Wen's confidence in the group’s future prospects and his belief in its long-term investment value. Such a substantial open-market purchase by a top executive is often viewed by the market as a bullish signal, suggesting that leadership believes the company's shares are undervalued.

Ad

Broader Sector Enthusiasm

Adding to the positive momentum, the AI-powered drug discovery sector received a boost from unrelated industry news. Reports that a peer company's subsidiary had entered into a drug discovery collaboration with Stanford University helped reinforce investor enthusiasm for the industry's potential.

This development highlights the growing validation of using AI platforms and small-molecule discovery technologies in partnership with academic institutions, a core area of XtalPi's business. The broader market provided a stable backdrop, with Hong Kong's Hang Seng Index trading in positive territory during the session.